Redox signaling through NADPH oxidases: Involvement in vascular proliferation and coagulation

Annals of the New York Academy of Sciences

Volumn 973, Issue , 2002, Pages 505-507

  Görlach, Agnes ^a   Kietzmann, Thomas ^b   Hess, John ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Angiogenesis; Coagulation; Endothelial cells; HIF 1; MAP kinase; NADPH oxidase; Oxygen radicals; Plasminogen activator inhibitor 1 (PAI 1); Proliferation; Redox; Signaling; Smooth muscle cells; Thrombin; Tissue factor; Vascular endothelial growth factor (VEGF)

Indexed keywords

ISOENZYME; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANGIOGENESIS; BLOOD CLOTTING; CELL PROLIFERATION; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ANALYSIS; NONHUMAN; OXIDATION REDUCTION REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOSIS; VASCULARIZATION;

EID: 0036963969     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04691.x     Document Type: Conference Paper

References (16)

1. THANNICKAL, V.J. & B.L. FANBURG. 2000. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 279: L1005-1028.
2. NAPOLI, C. 2001. Multiple role of reactive oxygen species in the arterial wall. J. Cell Biochem. 82: 674-682.
3. GRIENDLING, K.K. et al. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 86: 494-501.
4. BABIOR, B.M. 1999. NADPH oxidase: an update. Blood 93: 1464-1476.
5. JONES, S.A. et al. 1996. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271: H1626-H1634.
6. GÖRLACH, A. et al. 2000. A gp91phox-containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87: 26-32.
7. HEINLOTH, A. et al. 2000. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol. 11: 1819-1825.
8. DUERRSCHMIDT, N. et al. 2000.Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem. Biophys. Res. Commun. 269: 713-717.
9. GU, Y. et al. 2002. TNFalpha activates c-Jun amino terminal kinase through p47(phox). Exp. Cell Res. 272: 62-74.
10. SORESCU, D. et al. 2001. NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc. Med. 11: 124-131.
11. LAMBETH, J.D. 2002. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr. Opin. Hematol. 9: 11-17.
12. BARRY-LANE, P.A. et al. 2001. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 108: 1513-1522.
13. GÖRLACH, A. et al. 2001. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89: 47-54.
14. ABID, M.R. et al. 2001. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB J. 15: 2548-2550.
15. GÖRLACH, A. et al. 2000. Oxidative stress and expression of p22phox are involved in the upregulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J. 14: 1518-1528.
16. HERKERT, O. et al. 2002. p22phox mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation 105: 2030-2036.